Raynaud's phenomenon: a proposal for classification - PubMed
Review
. 1992 Sep-Oct;10(5):485-8.
Affiliations
- PMID: 1458701
Review
Raynaud's phenomenon: a proposal for classification
E C LeRoy et al. Clin Exp Rheumatol. 1992 Sep-Oct.
Abstract
Major confusion exists with regard to the definition of patients with Raynaud's phenomenon; defining the patient and the phenomenon are reasonably straightforward, but variations in the definition of its primary and secondary forms have created a situation in which the same patient might be classified as primary by one group and secondary by another. The present essay is a proposal for the strict definition of Primary Raynaud's Phenomenon (PRP) formulated as a hypothesis amenable to experimental testing. This hypothesis is tested retrospectively on a group of 240 patients with Raynaud's phenomenon. The proposed criteria permit classification in 215 of 240 cases or 89%, leaving 25 patients difficult to classify at initial evaluation. Further testing of the hypothesis is encouraged.
Similar articles
-
[Raynaud's phenomenon: pathogenesis and prevalence].
Mikulska D. Mikulska D. Ann Acad Med Stetin. 2010;56(1):11-4. Ann Acad Med Stetin. 2010. PMID: 21427808 Review. Polish.
-
O'connor CM. O'connor CM. J Vasc Nurs. 2001 Sep;19(3):87-92; quiz 93-4. doi: 10.1067/mvn.2001.117786. J Vasc Nurs. 2001. PMID: 11533581 Review.
-
Prevalence of Raynaud's phenomenon in a healthy Spanish population.
Riera G, Vilardell M, Vaqué J, Fonollosa V, Bermejo B. Riera G, et al. J Rheumatol. 1993 Jan;20(1):66-9. J Rheumatol. 1993. PMID: 8441168
-
ESVM guidelines - the diagnosis and management of Raynaud's phenomenon.
Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC, Visona A, Heiss C, Brodeman M, Pécsvárady Z, Roztocil K, Colgan MP, Vasic D, Gottsäter A, Amann-Vesti B, Chraim A, Poredoš P, Olinic DM, Madaric J, Nikol S, Herrick AL, Sprynger M, Klein-Weigel P, Hafner F, Staub D, Zeman Z. Belch J, et al. Vasa. 2017 Oct;46(6):413-423. doi: 10.1024/0301-1526/a000661. Epub 2017 Sep 12. Vasa. 2017. PMID: 28895508 Review.
-
[The natural course of Raynaud's phenomenon].
Clavijo F, Krahenbuhl B. Clavijo F, et al. Schweiz Med Wochenschr. 1981 Dec 19;111(51):2023-7. Schweiz Med Wochenschr. 1981. PMID: 7313657 French.
Cited by
-
Garner R, Kumari R, Lanyon P, Doherty M, Zhang W. Garner R, et al. BMJ Open. 2015 Mar 16;5(3):e006389. doi: 10.1136/bmjopen-2014-006389. BMJ Open. 2015. PMID: 25776043 Free PMC article. Review.
-
Is there any Sympathetic Skin Response Abnormality in Raynaud Phenomenon?
Emad MR, Farpour HR, Ahmed F, Tayebi M, Nazarinia M, Askarpour MR, Nikbakht HA. Emad MR, et al. Sultan Qaboos Univ Med J. 2022 May;22(2):274-279. doi: 10.18295/squmj.4.2021.066. Epub 2022 May 26. Sultan Qaboos Univ Med J. 2022. PMID: 35673285 Free PMC article.
-
Digital thermography of the fingers and toes in Raynaud's phenomenon.
Lim MJ, Kwon SR, Jung KH, Joo K, Park SG, Park W. Lim MJ, et al. J Korean Med Sci. 2014 Apr;29(4):502-6. doi: 10.3346/jkms.2014.29.4.502. Epub 2014 Apr 1. J Korean Med Sci. 2014. PMID: 24753696 Free PMC article.
-
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy.
Mondini L, Confalonieri P, Pozzan R, Ruggero L, Trotta L, Lerda S, Hughes M, Bellan M, Confalonieri M, Ruaro B, Salton F, Tavano S. Mondini L, et al. Diagnostics (Basel). 2023 May 29;13(11):1905. doi: 10.3390/diagnostics13111905. Diagnostics (Basel). 2023. PMID: 37296759 Free PMC article. Review.
-
User preference for a portable syringe pump for iloprost infusion.
Laria A, Lurati AM, Re KA, Marrazza MG, Mazzocchi D, Farina A, Scarpellini M. Laria A, et al. Patient Relat Outcome Meas. 2015 May 19;6:139-44. doi: 10.2147/PROM.S81473. eCollection 2015. Patient Relat Outcome Meas. 2015. PMID: 26056502 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials